Postural Control in the Elderly

Cortical Control of Postural Stability in the Elderly

This study will examine loss of balance in the elderly. Falls due to balance problems are a major health issue in older people, often resulting in bone fractures and other bodily injuries, and functional decline. In addition, the fear of falling leads some elderly people to restrict their movements and social activities, causing depressed moods and decreased enjoyment of life. Risk factors for falling in the elderly include some standing positions in which older people usually experience balance problems, such as leaning forward or backward. This study will examine these unstable positions and the brain mechanisms associated with loss of balance in the elderly.

Normal volunteers between 20 and 90 years of age may be eligible for this study. Candidates must be in good health, with no difficulties in performing activities of daily living, and must be able to walk for at least 400 meters (1/4 mile). They will be screened with a medical history, physical examination, and blood tests.

Participants will undergo the following three experiments:

  • Movement task: The subject stands on a platform with markers placed at different parts of the body to record body movements. A cap with electrodes (metal disks) is placed on the head for electrocardiographic (EEG) recording of the electrical activity of the brain (brain waves) during the experiment. The positions of the feet on the platform are measured. While standing on the platform, the subject leans forward and backward as far as possible without losing balance. (Subjects are secured in a safety harness to prevent actual falls.) The task is repeated 5 times. The experiment lasts up to 2 hours.
  • Postural response task: This study is identical to the first, except that the subject does not voluntarily lean forward and backward, but is pushed with a device to cause forward and backward movements. The experiment lasts 1 to 2 hours.
  • Perceptual task: The subject sits in front of a computer screen and watches the postural movements of a human body model in forward and backward directions. When the subject recognizes an unstable position in the movements, he or she presses a computer mouse. An EEG records brain activity during the task, which lasts up to 2 hours.

Study Overview

Status

Completed

Detailed Description

A number of studies have explored the role of visual, vestibular and somatosensory systems in the control of upright posture. However, the cortical control of postural stability, in general, and the role of higher cognitive function in assessment of postural stability, in specific, has been less studied. It is well established that certain features of postural control change during the advancing years of life so that the stability of posture can be a problem in the elderly. However, neural mechanisms of postural stability that decline with age and make older adults more prone to falling have not been identified specifically. To characterize specific causes of falling in the elderly in problematic, because human posture is a product of an extremely complex dynamical system and like any other physical activity undergoes dramatic changes in organization throughout the life-span. In our previous research we showed the existence of specialized neural detectors that are embodied in spatiotemporal patterns of brain activiation (Slobounov et al., 200) capable of discrimination the unstable postures in dynamic situations. We propose that these neural detectors may deteriorate with aging, which result in difficulty to (a) initiate compensatory postural adjustments when balance is in danger, and (b) to discriminate relevant from irrelevant information in control of upright posture. This can be documented via changes in behavioral correlates of postural control and spatiotemporal patterns of the brain activation as a function of advanced age. Accordingly, the purpose of this study is to investigate the age-related cortical control of postural stability combining electroencephalography and postural control measures. This will be done when a subject physically approaches the postural stability boundary and when a subject solves a cognitive task identifying unstable postures in dynamic situations.

Study Type

Observational

Enrollment

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Bethesda, Maryland, United States, 20892
        • National Institute of Neurological Disorders and Stroke (NINDS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

INCLUSION CRITERIA:

Subjects will be enrolled in this balance study if they are within the range of 20-90 years old;

in good health;

report no difficulties or need for help in performing self-care or instrumental activities of daily living;

and are able to walk for at least 400 meters.

EXCLUSION CRITERIA:

We will be unable to study people who have substantial congitive impairment based on mental status screening tests;

history of cardiovascular disease (including angina, myocardial infarction, congestive heart failure, cerebro-vascular disease);

cancer;

neurological diseases;

birth defects;

kidney or liver disease;

gastrointestinal (G.I.) disease;

musculo-skeletal disorder (if they cause pathological weakness and/or chronic pain);

important sensory deficits and any conditions that precludes them from being tested with standard neurophyschological tests.

Pregnant women will be excluded from this study.

In addition, the following criteria are considered as markers of pathological conditions and are used as exclusion criteria for study enrollment:

  1. HIV virus infection;
  2. WBC greater than 12,000 ML;
  3. Platelets less than 100,000 or greater than 600,000/ML;
  4. Hemoglobin less than 11 gr/dl unless higher level can be ascribed to Gilbert's disease;
  5. Abnormal level of SGOT and SGPT and alkaline phosphetase twice the norm serum concentration;
  6. Corrected calcium less than 8.5 or 10.7 mg/dl;
  7. Albumin less than 3.4 g/dl;
  8. Shortness of breath while performing normal activities of daily living, such as walking or climbing stairs;
  9. evidence or history of cancer;
  10. absolute need for long term treatment with antibiotics, corticosteroids, immunosuppressors, H2 blockers and pain medications;
  11. any severe psychiatric condition such as subjects with Axis I psychiatric diagnosis;
  12. any condition that may preclude informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2003

Study Completion

March 1, 2005

Study Registration Dates

First Submitted

April 26, 2003

First Submitted That Met QC Criteria

April 25, 2003

First Posted (Estimate)

April 28, 2003

Study Record Updates

Last Update Posted (Estimate)

March 4, 2008

Last Update Submitted That Met QC Criteria

March 3, 2008

Last Verified

March 1, 2005

More Information

Terms related to this study

Other Study ID Numbers

  • 030165
  • 03-N-0165

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe